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Abstract
Background: Drug-therapy problems(DTPs) among hypertensive patients can result in patient’s morbidity and mortality. The 
main aim of  this study was to assess drug therapy problem and associated factors among <="" span="" style="font-family: 
hypertensive patients.
Methods: A hospital based cross sectional study was conducted. The data was collected from patients’ medical charts and 
through interview. Drug therapy problem was categorized according to Cipolle methods of  DTP classification. Thedata was 
analyzed using the Statistical Package for the Social Sciences (SPSS), version 21.
Results: A total of  241 patients were studied. The mean number of  antihypertensive medications prescribed were 1.41±0.53. 
A total of  357 drug therapy problems(DTPs) were identified. From the patients studied,134(55.6%) had at least one evidence 
of  drug therapy problem. Non adherence was the most commonly identified drug therapy problem occurred in (143(59.3%)) 
patients. Substance use (AOR=0.445, 95% CI= 0.227-0.870, p=0.018) and comorbidity (AOR= 2.099, 95% CI= 1.192-3.694, 
p=0.010) werethe predictors of  DTP.
Conclusion: More than half  of  the participants had evidence of  onset drug therapy problem. Thus efforts that could boost 
antihypertensive compliance and minimizes substance use should be adopted to reduce patients’s drug therapy problems.
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Background
Hypertension(HTN) is a silent killer disease in both de-
veloped and developing countries. It is among the lead-
ing risk factors for cardiovascular diseases and which is 
a major cause of  death globally.1,2 It is estimated that the 
world wide prevalence of  hypertension could increase 
from 26.4% in 2000 to 29.2% in 2025.3 By 2025, 125.5 
million people in sub-Saharan Africa will be expected to 
be affected by HTN.4
The prevalence of  hypertension in Ethiopia is escalating 
because of  increase in risk factors like smoking, obesity, 
harmful use of  alcohol and lack of  exercise. However, 
awareness about treatment and control of  hypertension is 
extremely low in Ethiopia.5 The intention of  prescribing 
drugs to patients is treatment, prophylaxis or diagnosis of  
medical conditions; however, these drugs may have nega-
tive effects on patients if  not used appropriately.6
Inadequate treatment of  hypertension can lead to conges-
tive heart disease(CHD), acute myocardial infarction(A-
MI), peripheral vascular disease(PVD), stroke, congestive 
heart failure(CHF) and renal failure. Because of  these it 
is the leading cause of  morbidity and mortality among 
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non-communicable diseases, and accounts for 13% of  all 
deaths globally.11,12,13,14
Analysis of  the global burden of  hypertension revealed 
that over 26% of  the world’s adult population had hy-
pertension in 2000 and has shown a rapid increase in 
prevalence affecting significant numbers of  individuals 
in sub-Saharan Africa. Although there is a shortage of  
extensive data, available data shows an overall prevalence 
of  5-20% in Oromo region.14,15 Despite the availability of  
effective medical therapy, more than half  of  hyperten-
sive patients on treatment has uncontrolled blood pres-
sure. This is mostly because of  drug therapy problems 
(DTPs).16,17,18,19
In Ethiopia the prevalence of  DTP ranged from 73.5-
80.7%.20,21 The most frequently identified cause for drug 
therapy problems are drug choice problems, dosing prob-
lems and/or drug interactions.18 On the other hand, pa-
tients usually had drug use problems caused by “drug use 
process, lack of  information, and physiological or patient 
factor.19
The occurrence of  DTP among hypertensive patients 
could prevent or delay patients from achieving desired 
therapeutic goals. It has been attributed to unnecessary 
over-prescription of  drugs, substantial worsening of  dis-
eases, avoidable increases in hospital admission rates, and 
longer hospital stays leading to a significant medical bur-
den. As a result, it resulted in poor health outcomes, low-
er quality of  life, increased health care costs and erodes 
public confidence in health systems.12,14
Interventions to improve DTPs are needed to overcome 
the harms imposed by the problem. If  such interven-
tions are to be successfully designed, targeted, and cost 
effective, it is critical to understand the complex reasons 
for drug therapy problems and to identify those that are 
modifiable in hypertensive patients. The aim of  the study 
was to assess DTPs and associated factors among adult 
hypertensive patients in Ayder Comprehensive Special-
ized Hospital(ACSH), Northern Ethiopia.
Research methods and participants
A hospital-based cross-sectional study among adult hy-
pertensive patients was conducted at the ambulatory 
hypertension clinic of  ACSH from March to June 2016. 
ACSH is located in Mekelle City, the capital of  Tigray 
Regional State, which is 783 km away from the capital 
of  Ethiopia, Addis Ababa. ACSH is the only teaching 
and referral hospital in the region. The hospital is having 
400 beds to serve its patients. It provides general out-
patient, inpatient and emergency services for about nine 
million people in the catchment area of  Tigray, Afar and 
South-eastern parts of  Amhara Regional States. ACSH 
provides general surgery and orthopedic, gynecology & 
obstetrics, pediatric and child health in addition to inter-
nal medicine, dermatology, psychiatric and dental services 
to the general public.
There were 2113 registered hypertensive patients at the 
ambulatory clinic of  ACSH. Single proportion formula 
was used to calculate the minimum sample size needed. 
Considering 1.96 for the standard normal variable with 
5% level of  significance (α - value), 0.8 prevalence of  
DTP in Adama, Ethiopia,9  95% confidence interval, 5% 
margin of  error and 10% contingency, the sample size 
was calculated to be 241.
The study was approved by the Institutional Ethical 
Review Board of  College of  Health Sciences, Mekelle 
University. ACSH also give permission the study to be 
conducted on the hypertensive clinic. Informed written 
consent was obtained from all patients prior to face to 
face interview. Patients personal information like name 
were not recorded to maintain patient’s confidentiali-
ty. A face-to-face interview using a pretested structured 
questionnaire was conducted to collect the socio-demo-
graphics, clinical characteristics and adherence status of  
patients to antihypertensive medication(s). Data on co-
morbidities, antihypertensive medications and a one-year 
blood pressure(BP) measurements were extracted from 
medical records of  patients using a pretested data ab-
straction checklist.
All hypertensive patients aged 18 years and above, who 
had a regular follow-up for at least 12 months at ACSH 
hypertension clinic and whose medical records contained 
complete data and who were willing to participate were 
included in the study. Seriously ill patients who were not 
able to finish interview and patients with incomplete 
medical records were excluded from the study. The data 
were collected by trained clinical nurses working out of  
ACSH.
To maintain validity of  the data collection tool, a struc-
tured questionnaire was developed and translated into 
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local languages (Amharic and Tigrigna) and back trans-
lated to English. The primary outcome of  the study was 
presence of  DTP.
Classification of  drug therapy problem
DTP was identified with reference to Joint National com-
mittee (JNC-8). Drug therapy problem was categorized 
according to a Cipollea method of  DTP classification. 
There are seven basic categories of  DTPs according to 
the book. These are: indication, effectiveness, safety and 
adherence.22 The DTPs and their possible causes were 
identified from the patients’ medical records and patients 
interview.
Variables
The dependent variable was presence of  DTP where-
as the independent variables were age, sex, number of  
drugs, co-morbidity, socio-demographic characteristics, 
substance use, occupation, number of  anti-hypertension 
medications, life style modification, mode of  medication 
intake i.e. free or pay, duration of  hypertension since di-
agnosis and family history of  hypertension.
Operational definitions
Hypertension was defined as sustained high blood pres-
sure (SBP≥140 or DBP ≥90mmHg) or reported regu-
lar use of  antihypertensive medication(s).Uncontrolled 
blood pressure was defined as systolic blood pressure 
of  ≥140 mmHg and/or diastolic blood pressure of  ≥90 
mmHg.9 Controlled blood pressure was defined as systol-
ic blood pressure of  <140 mmHg and/or diastolicblood 
pressure of  < 90 mmHg.9 A DTP is defined as any unde-
sirable event experienced by a patient which involves, or 
is suspected to involve, drug therapy, and that interferes 
with achieving the desired goals of  therapy, which can 
be identified using JNC-8 guidelines except compliance.23 
Any deviation from the JNC-8 guideline protocol was de-
clared to have DTP.
Statistical analysis
Data was analyzed using Statistical Package for Social 
Sciences (SPSS® statistics) program version 21 (SPSS; 
Chicago, IL, U.S.A). Binary logistic regression analysis 
was employed to identify determinants of  drug related 
problems. To identify determinants of  DTP, variables 
with p-values < 0.05 on a univariable/span> logistic re-
gression model were entered into a multivariable logistic 
regression model and variables with tailed p-value < 0.05 
were considered as statistically significant and were de-
clared to be determinants of  DTP.
Results
Baseline characteristics of  the participants
A total of  241 adult hypertensive patients were en-
rolled and studied. The response rate was 100%. From 
the total patients studied, 142 (58.9%) participants were 
males. The average mean age of  the participants was 
45.11±11.79 years with minimum peak age of  21 and 
maximum peak age of  73 years. Regarding age catego-
ry of  the patients, 69(28.6%) patients were in the ages 
of  45-54 years, 57(23.7%) less than 35 years, 56(23.2%) 
between 35-44 years and 13(5.4%) were 65 and above 
years. In addition, most, 197(81.7%) patients were mar-
ried, 19(7.9%) widowed, 18(7.5%) single and 7(2.9%) 
divorced. Concerning level of  education of  the partici-
pants, most [137(56.8%)] of  the patients had no formal 
education, 65(27%) were college and above, 24(10%) 
complete elementary (1-8) school and 15(6.2%) complete 
high school (9-12). Of  all the participants, 126(52.3%) 
were private workers, 56(23.2%) government employee, 
41(17%) jobless,12(5%) students, and 6(2.5%) employed 
on non-governmental organizations.
Antihypertensive medications
Patients were prescribed one or two or three antihyperten-
sive medicines. The average mean number of  antihyper-
tensive medicines prescribed for patients was 1.41±0.53 
ranging from 1-3 medications per patient. From the total 
participants studied, enalapril was the most common-
ly prescribed medication in most of  the patients. It was 
prescribed for 148(61.5%) patients and hydrochlorothia-
zide(HCT) was prescribed for 86(35.8%) patients (table 
1).
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Table 1: Most frequently prescribed medications for HTN treatment at  
Ayder Comprehensive Specialized Hospital, March to June 2016 
 
Type of medication Frequency Percent 
Enalapril 148 61.5 
HCT 86 35.8 
Nifedipine 63 26.1 
Amilodipine 36 15.0 
Atenolol 4 1.6 
Propranolol 4 1.6 
Methyldopa 1 0.4 
          
                       HCT: Hydrochlorothiazide, HTN: Hypertension 
Drug therapy problem and associated factors
A total of  357 DTPs were identified in 241 patients and 
the most common prevalent type of  DTP identified was 
non adherence, which was identified in 143(40.1%) pa-
tients. Among the patients, 134(55.6%) had at least one 
identified DTP. From the patients having DTP, most 
(n=76, 56.7%) of  the patients had one type of  DTP and 
53(39.6%) patients had identified with two DTPs. Patients 
having uncontrolled blood pressure were more likely to 
have DTP as compared to patients who had controlled 
BP (COR=0.567, 95 % CI=0.332-0.967, p=0.037). Ther-
apeutic non-adherence was the most commonly identi-
fied DTP which was found to be identified in 143 (59.3%) 
patients (table 2). 
Table 2: DTP and types of DTPs identified at Ayder 
 Comprehensive Specialized Hospital, March to June, 2016  
 
Variables Number/patient Percent(%) 
Presence of DTP Patient   
    Yes 134 55.6 
    No 107 44.4 
Number of DTP Number   
One 76 56.7 
Two 53 39.6 
Three 4 3.0 
Four 1 7.0 
Total 134 100.0 
Type of DTP Number   
   Adherence Non-adherence 143 40.1 
Indication Needs additional drug therapy 61 17.1 Unnecessary drug therapy 40 11.2 
Safety Adverse drug event 6 1.7 Dose too high 3 0.8 
Effectiveness Dose too low 60 16.8 Ineffective drug use 44 12.3 
Total DTPs identified 357 100 
 
               DTP: Drug therapy problem, DTPs: Drug therapy problems 
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The respondents’ adherence was found to be affect-
ed by different factors
We conducted bivariable logistic regression and Sub-
stance use (COR=0.449,95%CI:0.231-0.87, p=0.018) and 
comorbidity (COR=2.084, 95%CI:1.192-3.65, p=0.010) 
were significantly associated with DTP (table 3).
Table 3: Bivariable logistic regression analysis of variables associated with presence of drug therapy problem 
among adult hypertensive patients in ACSH, March to June, 2016. 
 
Variable Drug therapy problem COR (95%CI), p-value 
No Yes 
Sex 
 Male 61(43%) 81(57%) 1 
 Female 42(42.4%) 57(57.6% 0.978(0.582-1.64)p=0.934 
Age 
≤35 year old 28(49.1%) 29(50.9%) 1 
35-44 23(40.4%) 34(59.6%) 1.43(0.68-2.99)p=0.347 
45-54 32(46.4%) 37(53.6) 1.12(0.553-2.25)p=0.759 
55-64 17(37%) 29(63%) 1.65(0.75-3.64)p=0.217 
≥65 3(27%) 9(75%) 2.897(0.710-11.87)p=0.138 
Marital status 
Single 8(44.4%) 10(55.6%) 0.989(0.374-2.611)p=0.982 
Married 87(44.2%) 110(55.8%) 1 
Divorced 2(28.6%) 5(71.4%) 1.977(0.375-10.44)p=0.422 
Widowed 6(31.6%) 13(68.4%) 1.71(0.63-4.69)p=0.295 
Residence 
Urban 59(41.8%) 82(58.2%) 1 
Rural 44(44%) 56(56%) 1.09(0.651-1.832)p=0.739 
Education level 
No formal 56(40.9%) 81(59.1%) 1 
Elementary (1-8) 12(50%) 12(50%) 0.691(0.29-1.65)p=0.405 
High school (9-12) 7(46.7%) 8(53.3%) 0.79(0.271-2.304)p=0.666 
College and above 28(43.1%) 37(56.9%) 0.914(0.503-1.66)p=0.767 
Occupation 
Employed 27(43.5%) 35(56.5%) 1 
Private worker 58(46%) 68(54%) 0.904(0.490-1.67)p=0.748 
Jobless 18(34%) 35(66%) 1.5(0.703-3.207)p=0.295 
Family history of hypertension 
No 72(42.9%) 96(57.1%) 1 
Yes 31(42.5%) 42(57.5%) 0.984(0.565-1.72)p=0.955 
HTN duration in years 
≤5 65(44.5%) 81(55.5%) 1 
6-10 25(43.9%) 32(56.1%) 1.027(0.554-1.903)p=0.932 
11-15 6(37.5%) 10(62.5%) 1.337(0.462-3.874)p=0.592 
16-20 7(31.8%) 15(68.2%) 1.72(0.662-4.467)p=0.266 
Salt intake 
No 45(45%) 55(55%) 1 
Yes 58(41.1%) 83(58.9%) 0.854(0.509-1.433)p=0.550 
Physical activity 
Physically inactive 101(43.7%) 130(56.3%) 1 
Physically active 2(20%) 8(80%) 0.322(0.067-1.55)p=0.157 
Substance use 
No 88(46%) 100(53.2%) 1 
Yes 15(28.3%) 38(71.7%) 0.449(0.231-0.87)p=0.018* 
Mode of medication intake 
Free 34(37.8%) 56(62.2%) 1 
Paid 69(45.7%) 82(54.3%) 0.722(0.423-1.230)p=0.230 
Number antihypertensive medication 
Monotherapy 57(38.8%) 90(61.2%) 1 
≥ two medications 46(48.9%) 48(51.1%) 0.661(0.392-1.12)p=0.121 
Comorbidity 
No 77(48.7%) 81(51.3%) 1 
Yes 26(31.3%) 57(68.7%) 2.084(1.192-3.65)p=0.010* 
       
      *: p value<0.05, 1: Reference, COR: Crude odds ratio, CI: Confidence interval 
African Health Sciences Vol 19 Issue 3, September, 20192575
0.227-0.870, p=0.018) and comorbidity (AOR= 2.099, 
95% CI= 1.192-3.694, p=0.010) were found to be the 
predictors of  DTP. Patients who reported substance use 
were less likely to have DTP than patients who did not 
use substance. Moreover, patients who had evidence of  
comorbidity were 2 times more likely to have DTP than 
patients who did not have evidence of  comorbidity (table 
4).
Multivariable logistic regression was employed to iden-
tify the predictors of  drug therapy problem. The anal-
ysis model explains 52.3% (R2=0.523, p=0.002) of  the 
DTP variability of  the response data  confined around 
its mean. Two variables (substance use and comorbidity) 
were significantly associated with DTP in the bivariable 
logistic regression and after we conducted multivariable 
logistic regression, substance use (AOR=0.445, 95% CI= 
Table 4: Multivariable logistic regression analysis of variables associated with presence of drug therapy 
problem among adult hypertensive patients in ACSH, March to June, 2016. 
 
Variable Drug therapy problem COR (95%CI)p-value AOR(95%CI), p-value 
No Yes 
Substance use 
No 88(46%) 100(53.2%) 1 1 
Yes 15(28.3%) 38(71.7%) 0.449(0.231-0.87)p=0.018* 0.445(0.227-0.870)p=0.018* 
Comorbidity 
No 77(48.7%) 81(51.3%) 1 1 
Yes 26(31.3%) 57(68.7%) 2.084(1.192-3.65)p=0.010* 2.099(1.192-3.694)p=0.010* 
        
      *: p value<0.05, 1: Reference, COR: crude odds ratio, AOR: Adjusted odds ratio, CI: Confidence interval 
Discussion
The prevalence of  DTP identified in this study was ac-
counted to be 55.6%. This is not consistent with the 
study done in Felege Hiwot Referral Hospital, South west 
Ethiopia. There were 357 numbers of  DTPs, on the oth-
er hand, a less number of  DTPs (105) was found in the 
study done in Felege Hiwot referral Hospital.24,25 This 
might be due to the fact that the study in Felege Hiwot 
Referral Hospital enrolled and studied small number of  
medical patients. The mean number of  DTP was 1.48 ± 
0.597 which is comparable with the findings reported in 
Jimma which was 1.8 ± 0.8.25
The most common DTP identified was non-adherence 
which was identified in 143(59.3%) of  the patients. This 
result is consistent with the study conducted in Southern 
Kivu province of  the Democratic Republic Congo and 
Ghana.26,27 However, this was incongruent with the study 
done in Mexico which found a non-adherence prevalence 
of  42.8%.28 A study conducted in Southern Kivu of  
DRC showed that 86.4% of  hypertensive patients were 
non-adherence which is not in lined with this study.20 This 
difference may be due to uncertainty or lack of  knowl-
edge about the aim or function of  the drug, economic is-
sue and long duration of  therapy. The result in this study 
found DTP which was dose too high (1.2%) which is not 
in line with the result of  research done in China which 
was (19.1%).29 This difference may be due to frequent 
administration of  the antihypertensive medications.
Adverse drug events were occurred in 1.7% of  the pa-
tients studied. This is not in line with research done in 
Sweden and in India which showed a prevalence of  ad-
verse drug event to be 25.7% and 10% respectively.30,31 
This may be because of  difference in patient knowledge 
on which drug is the cause for adverse effect occurred, 
poor documentation and poor habit of  adverse drug 
event report by patients.
Of  the total type of  DTPs, 11.2% was unnecessary drug 
therapy. This is not in line with findings from India which 
reported a prevalence of  unnecessary drug therapy to 
be 16.7%. Moreover, dose related problems (25.9%) fol-
lowed by need for additional drugs (25%) in this study 
are not in line with the study done in India which were 
35.1% and 19.7% respectively.25,32 A study conducted in 
South America, Brazil on the existence of  DTPs showed 
that 44% was dosage too low which is not in line with this 
study which found dosage too low to be 16.8%.33
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A study conducted in China regarding drug related prob-
lems found that,24.1% were ineffective indication which 
is not in line with this study which described a prevalence 
of  ineffective indication to be 12.3%.29  This may be be-
cause of  prescribing errors. In this study we also found 
that substance use and comorbidity were the predictors 
of  DTP.
This study has some flaws and limitations. First because 
some data were collected through interview there might 
be recall bias especially during antihypertensive medi-
cation adherence status assessment. Second the effect 
of  DTP on outcome of  hypertension was not studied. 
Thirdly the identified DTPs were not intervened. Fourth 
some six seriously ill patients were excluded from the 
study thus this might affect the finding of  the study.
Conclusion
More than half  of  the patients studied had identified 
with at least one DTP. Non-adherence to antihyperten-
sive medications was the most commonly identified DTP. 
Thus efforts that boost antihypertensive compliance 
should be adopted to solve drug related problem of  hy-
pertensive patients.
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